Biotech Acoramidis Demonstrates Reversal of Cardiac Structural Disease Progression and Functional Decline and Significantly Increases Days Alive and Free from Hospitalization in ATTR-CM August 31, 2026
Biotech HUTCHMED Announces SANOVO Trial Demonstrated Significant Progression-Free Survival Benefit of ORPATHYS® Plus TAGRISSO® in Treatment-Naïve Patients with MET-Overexpressing EGFR-mutated Lung Cancer in China August 31, 2026
Biotech Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 August 30, 2026
Biotech 20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity August 29, 2026
Biotech Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome August 28, 2026
Biotech BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals August 28, 2026
Biotech Quoin Pharmaceuticals Announces Private Placement Financing of Up to $50.0 Million August 28, 2026
Biotech HUTCHMED Announces NMPA Approval for ATLED® (Fanregratinib) for the Treatment of Patients with FGFR2-Fusion/Rearrangement Intrahepatic Cholangiocarcinoma August 28, 2026
Biotech TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS August 27, 2026
Biotech AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn’s Disease August 27, 2026
Search
Biotech
August 31, 2026
August 31, 2026
August 30, 2026
August 29, 2026
August 28, 2026
August 28, 2026
August 28, 2026
August 28, 2026
August 27, 2026
August 27, 2026
